Status:
COMPLETED
Quadratus Lumborum Block Versus Control for Total Hip Arthroplasty
Lead Sponsor:
University of Alabama at Birmingham
Conditions:
Total Hip Arthroplasty
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
Peripheral nerve blocks for joint and extremity surgeries have long been proven to provide effective post-operative analgesia. Of these surgeries, total hip arthroplasty (THA) remains one of the most ...
Detailed Description
Currently, regional anesthesia techniques for total hip arthroplasty are limited. Fascia iliac blocks have been employed to provide analgesia for hip surgeries with blockade of the femoral, lateral fe...
Eligibility Criteria
Inclusion
- Patients undergoing total hip arthroplasty
- Adults 18 years of age and older
- Patients with an American Society of Anesthesiology (ASA) physical status classification of I, II or III
Exclusion
- Patients with ASA physical status classification other than I, II, or III
- Patients with allergies/intolerances to local anesthetic
- Patients with pre-existing neurologic or anatomic deficits in the lower extremity on the side of the surgical site
- Patients with coexisting coagulopathy
- Patients that are pharmacologically anticoagulated will be excluded if placement of peripheral nerve block would be contraindicated according to ASRA (American Society for Regional Anesthesia) guidelines or if spinal anesthesia would be contraindicated according to guidelines
Key Trial Info
Start Date :
April 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 22 2020
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03408483
Start Date
April 1 2018
End Date
August 22 2020
Last Update
June 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35233